Skip to main content

Table 2 CMR characteristics of control subjects versus patients with PH

From: Left ventricular diastolic dysfunction in pulmonary hypertension predicts functional capacity and clinical worsening: a tissue phase mapping study

 

Normal

PH patient

p-value

RVEDV (mL)

130 (104–156)

158 (128–204)

0.0056

RVESV (mL)

38 (31–63)

103 (70–133)

<0.00001*

RVSV (mL)

87 (74–99)

62 (48–75)

0.0006*

RVEF

65 ± 8

40 ± 12

<0.00001*

LVEDV (mL)

134 (108–139)

88 (74–109)

0.0001*

LVESV (mL)

42 ± 16

32 ± 13

0.012

LVSV (mL)

85 ± 19

62 ± 18

<0.00001*

LVEF

67 ± 8

66 ± 9

0.61

LV cardiac output (L/min)

5.6 (4.8–6.4)

4.6 (3.8–5.5)

0.0094

Septal curvature

1.09 ± 0.10

−0.20 ± 0.58

<0.00001*

E/A ratio

1.56 (1.23–2.88)

1.33 (1.11–2.36)

0.31

  1. Values are mean ± SD, or median (interquartile range)
  2. *indicates statistical significance (p < 0.0018 following Bonferroni correction)
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us